<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
    <title>Noradrenergic and Specific Serotonin Antidepressants (NaSSAs)</title>
	</head>
  <body onload="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="inline">
    	<h1>NaSSAs</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<ul data-role="listview" data-inset="true" >
		<li><a href="brands/mirtazapine.html" >Mirtazapine (Remeron)</a></li>	
	</ul>	
	<a href="adverse_effects.html" data-role="button" data-icon="arrow-r" data-iconpos="right">Adverse Effects</a>
	<a href="pro_con.html"data-role="button" data-icon="arrow-r" data-iconpos="right">Pros and Cons</a>
	<a href="monitor_referrals_warn.html" data-role="button" data-icon="arrow-r" data-iconpos="right">Monitoring, Referrals and Warnings</a>
	<a href="blackbox.html" data-theme="a" data-role="button" data-icon="arrow-r" data-iconpos="right">Black Box Warning</a>
	    <div data-role="content">
  	<p>SSRIs, SNRIs, bupropion, mirtazapine are first line therapy for adults with Major Depressive Disorder (MDD). Use with caution in seizure disorder, elderly patients, hepatic or renal impairment. Adjust dose in CRCL &lt; 40ml/min. Use with caution in hepatic impairment. Start with lowest dose with gradual titration.</p>    	
     </div>
 
    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
